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forces as well as the general shape of kinematics’ curves were
also compared with in vivo curves described in the literature.
Results: Data recorded during in vitro simulations highlighted
average intra-specimen variability less than 0.8° and 0.7 mm
for the three rotations and translations of the stiﬂe respectively,
compared with 5.8° and 1.3 mm for the inter-specimen variability.
The comparison of the six average curves of movements collected
on the tested stiﬂes to those from in vivo trials reveals similar
patterns in every case. However, amplitude of movement is slightly
greater on in vivo curves. Peak vertical forces measured in the
device (138±2 N) were also similar to in vivo trials reported in the
literature.
Conclusions: Results show that the device generates reliable
motion on a loaded limb which are representative of the in vivo
3D kinematics presented in the literature. The validation of the
model is the ﬁrst step to understanding the inﬂuence of OA on
3D kinematics. This model could be adapted and used with the
human knee in ex vivo studies.
099
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Purpose: Rotator cuff tears of the shoulder are a common cause
of pain, disability and shoulder osteoarthritis. The surgical re-
constructive procedures for rotator cuff tears present a number of
limitations. The few studies in which the repair integrity is evaluated
have shown the existence of a high rate of re-ruptures in spite of
the fact that the short-term functional results are satisfactory. Mor-
phologic analysis of the sutures, after different follow-up periods,
has not shown satisfactory results. Therefore, giving the relatively
poor result of surgical intervention, new approaches need to be
developed. In this study, we have established an animal model
of chronic rotator cuff tears to study supraspinatus (SE) tendon
characteristics at the insertion site as occurs in human pathology.
Methods: Unilateral surgery was performed in 18 mature rats
(9 months old) to detach the SE tendon insertion sites. Under
aseptic operating room protocols, deltoid muscle was detached
sharply from acromion. The SE was visualized and then exposed
by external rotation of the humerus, SE was detached sharply at
the bone insertion site. Fibrocartilage was removed at the insertion
site by scraping with a scalpel blade and SE tendon was allowed
to freely retract. The overlying deltoid muscle and skin was closed.
Contralateral shoulder was used as a control. Rats were sacriﬁed
at 1 month (n=6), 2 month (n=6) and 4 month (n=6) post-injury.
- Histologic analysis: the natural healing response was evaluated
by quantitative collagen ﬁber orientation. 5μm sections from the
injured shoulder of three animals in each group were stained
with hematoxylin and eosin. SE muscle and tendon, the proximal
humerus, and any scar tissue that ﬁlled the tendon-bone defect
were included into the sections. Collagen organization analysis
was evaluated using a quantitative polarized light microscopy.
- Biomechanical analysis: Remaining three specimens in each
group were used for biomechanical analysis. SE was isolated
by detaching the tendon and muscle from all surroundings tis-
sues. Each specimen were then immersed at 39°C, preloaded to
0.1Newtons (N), preconditioned for 10 cycles from 0.1 to 0.5N at
a rate of 3%/s, and held for 300s. Just following that, a stress
relaxation experiment was performed. Ramp to failure was then
applied at a rate of 0.3%/s. Tendon-humerus specimens were
performed with the specimen at 90 degrees of abduction in an
electro mechanic Instron 5866 machine.
Results: Control specimens showed a normal four-zone tendon-
bone transition consisting of tendon, ﬁbrocartilage, mineralized
ﬁbrocartilage and bone. The injury model did not show any of
these zones and tendon defect remains unﬁlled and/or partially
disrupted; collagen organization was also disrupted in the injury
model. This tendon mimics tendon appearance of human chronic
rotator cuff tears.
Biomechanical tests showed that maximum resistance, previous to
rupture, in the control group was 38Newtons (N). In contrast, only
a minimal resistance, less than 5N in all cases, was observed in
the case of injury model. Also in all cases, tendon rupture during
mechanical test occurred at the tendon-bone insertion site. No
signiﬁcant differences were observed in histological or mechanical
tests at 1, 2 and 4 months.
Conclusions: These data suggest that our rat model of rotator
cuff disease is an appropriate in vivo animal model to study
chronic rotator cuff disease. Different suture approaches together
with BMPs, growth factors and/or Mesenchymal Stem Cells could
be easily tested in this model in order to obtain a much better heal
of tendon and to prevent secondary shoulder osteoarthritis.
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Purpose: Osteoarthritis (OA) is a chronic degenerative disease
characterized by progressive loss of articular cartilage, subchon-
dral bone sclerosis, osteophyte formation and changes in the
synovial lining. Due to the localized nature of the disease, dosing
therapeutics intra-articularly (IA) is an attractive delivery approach
for OA, and it is already established in the clinic for delivering
corticosteroids and viscosupplements. To deliver a biologic or a
recombinant protein IA, it is important to know how long the
molecule will be retained in the joint. The purpose of this research
was to assess the pharmacokinetics of a monoclonal antibody in
the knee joint following IA and systemic delivery to normal rats.
Methods: A non-speciﬁc monoclonal antibody not known to cross-
react with rat protein was injected IA into the knee joint or intraperi-
toneally (ip) into normal Sprague Dawley rats. Synovial ﬂuid knee
lavage and serum samples were collected at various time periods
following dosing and antibody concentrations were determined by
ELISA. To control the dilution of synovial ﬂuid from the lavage,
antibody levels in the lavage were normalized by measuring and
comparing urea concentrations in the lavage and serum. To un-
derstand the distribution of antibody in joint tissues, radiolabeled
antibody was injected IA and joint (including bone, cartilage and
synovium), synovial ﬂuid lavage, and blood samples were col-
lected at various time-points. Radioactivity in the tissue and body
ﬂuid samples was measured by scintillation counting. Finally, two
radiolabeled antibodies were dosed IA and compared for their
retention in the joint after 10 minutes and 24 hours by the method
described above. One antibody was non-speciﬁc and not known
to cross-react with rat while the other was speciﬁc to rat type II
collagen.
Results: We demonstrated that approximately 5% of the non-
speciﬁc antibody could be detected in the synovial ﬂuid 12 hours
after ip administration to normal rats. Following IA dosing, the
non-speciﬁc antibody was cleared from the synovial ﬂuid and the
joint tissue with a half-life in the range of 8-9 and 12 hours, respec-
tively. Approximately 20% of the non-speciﬁc antibody appeared
in the blood 24 hours post IA dosing. Signiﬁcantly higher levels
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of radiolabeled anti-rat type II collagen antibody were detected in
the synovial ﬂuid 10 minutes and 24 hours post-IA administration
relative to the non-speciﬁc antibody.
Conclusions: Rapid clearance of a non-speciﬁc antibody from
the synovial ﬂuid and joint tissues is observed after IA dosing
to a normal rat knee joint. The data highlights that if sustained
drug exposure is required for efﬁcacy, the retention time of the
therapeutic needs to be increased. Sustained retention of an anti-
collagen II antibody in the rat joint suggests that binding to a
resident protein may extend antibody retention time.
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Purpose: Methods of producing relevant and quantiﬁable load
alterations in vivo with which to study load-induced cartilage de-
generation are limited. A novel loading device has been developed
to apply a varus moment to the knee creating a chronic overload
to the medial compartment of the knee while allowing normal joint
function. The objective of this study is to conﬁrm the change in
load in the medial compartment of the rabbit knee with application
of a known target load.
Methods: The increase in medial compartment compressive load
generated by the Varus Loading Device (VLD) was measured
directly in vitro and compared to the predicted values. The VLD
is mounted via transcutaneous bone plates attached to the lateral
aspect of the femur and tibia (Fig. 1). The VLD allows moments to
be applied only during the designated treatment period, at other
times the moment can be disengaged by detaching the distal
portion of the load link.
Figure 1. VLD applied to a hind limb: (A) lateral view, (B) anterior view. Ap-
plication of the VLD results in an increase in compressive load in the medial
compartment by an amount P. The change in load can be modulated in a
controlled manner by setting the spring torque as shown by Eqn. 1 where: P
= change in contact load, T = torque setting of the spring, D = intercompart-
mental moment arm, L1 = load link moment arm, and L2 = tibia moment arm.
Eqn 1: P = T/D × L2/L1.
The VLD was installed on ﬁve, NZW rabbit, hind limbs. The
medial joint capsule was opened and the medial tibial plateau
was resected to a level 6 mm below the joint line. A load cell,
6mm dia. x 6mm tall, (ALD Design, NY) was inserted in the
resection cavity and cemented in place, maintaining the original
level of the joint line. The medial femoral condyle contacted the
load sensor ensuring that the entire compressive load developed
in the medial compartment was measured by the load cell. The
femoral head was mounted in a ball joint and the distal tibia was
ﬁxed in a clamp, positioned such that the femur was horizontal,
and the ﬂexion angle was approximately 115° to orient the tibial
plateau horizontally. A 100 N weight was attached to the femur
just proximal to the knee joint. This generated a compressive tibio-
femoral load approximately equally divided between the medial
and lateral compartments to simulate the physiologic joint load
normally present in the knee due to muscle activity, gravity and
inertial loads. The compression load cell was zeroed with this
static load in place. Moment arms were measured. The target
torque level was set and measured using a spring scale acting
over the moment arm L1. Three values of P were targeted: 25
N, 50 N, and 100 N. Using Eqn. 1, the spring torque required to
generate each of these was calculated and applied to the VLD
in succession and the actual P generated, as measured by the
load cell, was recorded.
Results: For all data points, the measured P was within 14%
of the target P (Fig. 2). The slope of the least squares ﬁt line
through the data points was not signiﬁcantly different than 1.
Figure 2. Measured vs. target values of P with VLD application.
Conclusions: These results demonstrate the overall feasibility
of applying a known compressive overload, P, to the medial
compartment of the knee using the VLD. The ability to apply
consistent load alteration to the knee will allow the future study of
the dose response of articular cartilage to quantiﬁed levels of load
alteration in vivo.
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Purpose: Osteophytes are a hallmark of osteoarthritis. In rheuma-
toid arthritis no osteophytes are found but profound bone depo-
sition is observed in ankylosing spondylitis. In animal models
the development of osteophytes is observed in both inﬂamma-
tory and degenerative joint diseases. In murine (osteo)arthritis
models, osteophyte formation appears to be the results of two
processes. New bone deposition via differentiating stem cells and
endochondral ossiﬁcation or through intramembranous deposition
by osteoblasts. We studied whether osteophyte formation differs
between murine inﬂammatory arthritis (IA) and osteoarthritis (OA),
and if dissimilar, what factors play a role in this unequal osteophyte
development.
Methods: We compared osteophyte formation in the following
OA models; spontaneous OA in Str/ort and collagenase-induced
osteoarthritis in C57Bl/6 mice. Inﬂammatory arthritis was studied
in collagen-induced arthritis in DBA-1J mice, streptococccal cell
wall-induced arthritis in C57Bl/6 mice and serum transfer-induced
arthritis in C57Bl/6 x 129Sv mice. Knee joints were dissected at
early as well as advanced time points during the development
